TickerSparkInvestor Intelligence
Spark Generator
Stock Deep Dives
AI Analyst
Agentic Chat
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio
My Portfolio
Brokerage Connected
Spark Charts
AI Technical Analysis
The Feed
Today's Market Intel
Stock Reports
AI Research Reports
Top Stocks
AI-Curated Stock Lists
Trending Stocks
Today's Big Movers
Earnings Coverage
Flashes & Deep Dives
Macro Updates
Economy & Markets
IPO Calendar
Upcoming Listings
Launch App
Log inCreate Account
← Back to TickerSpark
Earnings FlashRVTYHealthcareMedical - Diagnostics & Research

Revvity, Inc. (RVTY) rises on earnings beats

May 5, 20262 min read
Revvity, Inc. (RVTY) rises on earnings beats

Key Takeaway

Revvity, Inc. (RVTY) beat first-quarter earnings and revenue expectations, posting EPS of $1.06 versus $1.02 expected and revenue of $0.71 billion versus $0.70 billion expected. Shares jumped 7.03% as investors rewarded the company’s fifth straight quarter of EPS beats, signaling confidence in its consistent execution and improving sentiment around the stock.

Revvity, Inc. (RVTY) beat on both earnings and revenue, posting Q1 EPS of $1.06 versus $1.02 expected and revenue of $0.71B versus $0.70B expected, and the stock rose 7.03% in regular-session trading to $92.59.

Key Numbers

EPS: $1.06 actual vs $1.02 estimate, a beat.

Revenue: $0.71B actual vs $0.70B estimate, a beat.

Stock reaction: RVTY closed at $92.59, up 7.03% from the prior regular-session close of $86.51.

Intraday range: shares traded between $87.04 and $93.50 in the regular session.

Beat streak: Revvity has topped EPS estimates in each of the last five reported quarters, including $1.70 vs $1.57 in February 2026.

A small beat, but the market liked the pattern

The headline beat was modest, but it landed on top of a clean pattern. Revvity has now beaten EPS estimates for five straight quarters. That matters because consistency often carries more weight than a one-off pop, especially for a diagnostics and research tools name in a market that has punished uneven execution.

The 7.03% jump in regular-session trading shows investors treated this report as better than feared. Revenue also cleared estimates, even if only slightly, which helps support the idea that the quarter was not just an expense story. In plain English, Revvity did enough on both the top and bottom line to reset the tone around the stock.

TickerSpark

Institutional-grade market intelligence for the retail investor. Stop guessing. Start winning.

Product

  • Spark Generator
  • AI Analyst
  • Plans

Research

  • The Feed
  • Stock Reports
  • Macro Updates
  • Blog

Company

  • About Us
  • Contact

Legal

  • Terms of Service
  • Privacy Policy
  • Full Disclaimer
  • Cookie Policy

Notice: All content and data on TickerSpark is for informational purposes only and does not constitute financial or investment advice. All investments involve risk. Please see our Full Disclaimer for more details.

© 2026 Maxwell Cyberlogic LLC. All rights reserved.

Made in Delaware, USA.

This also fits the recent trend. The last five quarters all came in ahead of EPS expectations, from $1.01 vs $0.96 in April 2025 to $1.18 vs $1.14 in both July and October 2025, then $1.70 vs $1.57 in February 2026. Revvity is not blowing the doors off estimates, but it is stacking up beats, and for now that is doing the job.

Bottom Line

Revvity delivered another steady beat-and-raise-the-floor type quarter, and the stock's 7.03% regular-session gain says investors see that consistency as worth paying attention to.

Read the full RVTY research report

Frequently Asked Questions

+Why did Revvity stock rise today?

Revvity, Inc. (RVTY) rose 7.03% after reporting Q1 EPS of $1.06, above the $1.02 estimate, and revenue of $0.71 billion, slightly ahead of the $0.70 billion forecast. Investors also reacted positively to the company’s fifth consecutive quarter of beating EPS expectations.

+Did Revvity beat earnings and revenue estimates?

Yes. Revvity reported Q1 EPS of $1.06 versus the $1.02 consensus estimate and revenue of $0.71 billion versus $0.70 billion expected. The company beat on both the bottom line and the top line.

+How much did RVTY stock move after earnings?

RVTY closed the regular session at $92.59, up 7.03% from the prior regular-session close of $86.51. During the session, shares traded between $87.04 and $93.50.

+How many quarters in a row has Revvity beaten EPS estimates?

Revvity has beaten EPS estimates in each of the last five reported quarters. The streak includes the latest quarter at $1.06 versus $1.02 expected, along with prior beats such as $1.70 versus $1.57 in February 2026.

Want the full picture on RVTY?

Read the analyst-grade research report — charts, grades, and price targets.

Read the RVTY reportGet Full Access

Get the full RVTY research report

  • Analyst-grade deep dive
  • Charts, valuation, grades
  • Buy/sell price targets
Read the RVTY report

Trade smarter with AI-powered research

  • Daily market intelligence
  • AI stock analysis reports
  • Real-time chat with an AI analyst
Get Full Access

Free trial · Cancel anytime

More on RVTY

All articles
Revvity, Inc. (RVTY) rises on Q1 beat and deeper margin read
RVTY

Revvity, Inc. (RVTY) rises on Q1 beat and deeper margin read

Revvity, Inc. (RVTY) rises after a clean Q1 earnings beat, but the real story is in the details: stronger-than-expected margins, steady organic growth, and a guidance reset tied to a strategic China exit rather than core business weakness. Here’s what the numbers and outlook really mean.

5/5/2026 10 min
Revvity (RVTY): Recovery Story With Software Upside
RVTY

Revvity (RVTY): Recovery Story With Software Upside

Revvity is a balanced life sciences and diagnostics operator with improving earnings, solid cash flow, and a growing software mix. The stock looks more like a recovery rerating than a breakout, but valuation is reasonable if forward EPS delivers.

5/5/2026 21 min
xAI Is Private. Here’s How Investors Can Still Get Exposure

xAI Is Private. Here’s How Investors Can Still Get Exposure

No, xAI is not publicly traded. Retail investors mostly have to wait for a future IPO, look at the public parent if one exists, or use comparable AI stocks and accredited-only private markets.

5/20/2026 6 min